KASL clinical practice guidelines for management of chronic hepatitis B
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jang, Jeong Won | - |
dc.contributor.author | Park, Jun Yong | - |
dc.contributor.author | Kwon, Jung Hyun | - |
dc.contributor.author | Yu, Su Jong | - |
dc.contributor.author | Kang, Wonseok | - |
dc.contributor.author | Chon, Young Eun | - |
dc.contributor.author | Kim, Tae Hyung | - |
dc.contributor.author | Choi, Jonggi | - |
dc.contributor.author | An, Jihyun | - |
dc.date.accessioned | 2022-07-06T05:14:52Z | - |
dc.date.available | 2022-07-06T05:14:52Z | - |
dc.date.created | 2022-06-03 | - |
dc.date.issued | 2022-04 | - |
dc.identifier.issn | 2287-2728 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/138811 | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ASSOC STUDY LIVER | - |
dc.title | KASL clinical practice guidelines for management of chronic hepatitis B | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | An, Jihyun | - |
dc.identifier.doi | 10.3350/cmh.2022.0084 | - |
dc.identifier.scopusid | 2-s2.0-85129710875 | - |
dc.identifier.wosid | 000787904100004 | - |
dc.identifier.bibliographicCitation | CLINICAL AND MOLECULAR HEPATOLOGY, v.28, no.2, pp.276 - 331 | - |
dc.relation.isPartOf | CLINICAL AND MOLECULAR HEPATOLOGY | - |
dc.citation.title | CLINICAL AND MOLECULAR HEPATOLOGY | - |
dc.citation.volume | 28 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 276 | - |
dc.citation.endPage | 331 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002829249 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | TENOFOVIR DISOPROXIL FUMARATE | - |
dc.subject.keywordPlus | STEM-CELL TRANSPLANTATION | - |
dc.subject.keywordPlus | HEPATOCELLULAR-CARCINOMA RISK | - |
dc.subject.keywordPlus | VIRUS HBV REACTIVATION | - |
dc.subject.keywordPlus | CORE-RELATED ANTIGEN | - |
dc.subject.keywordPlus | TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION | - |
dc.subject.keywordPlus | SERUM ALANINE AMINOTRANSFERASE | - |
dc.subject.keywordPlus | SEVERE ACUTE EXACERBATION | - |
dc.subject.keywordPlus | TREATMENT-NAIVE PATIENTS | - |
dc.subject.keywordPlus | COMPENSATED CIRRHOSIS PATIENTS | - |
dc.subject.keywordAuthor | Chronic hepatitis B | - |
dc.subject.keywordAuthor | Treatment | - |
dc.subject.keywordAuthor | Disease management | - |
dc.subject.keywordAuthor | Therapeutics | - |
dc.subject.keywordAuthor | KASL guidelines | - |
dc.identifier.url | https://www.e-cmh.org/journal/view.php?doi=10.3350/cmh.2022.0084 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.